Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Laboratories Inc. /DE/ Director's Dealing 2025

Oct 2, 2025

32685_dirs_2025-10-02_3a0a49fd-372e-43ce-8ab1-053182e299ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2025-10-01

Reporting Person: Teo Sow Hang (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-10-01 Common Stock F 99 $12.58 Disposed 7901.334 Direct
2025-10-01 Common Stock M 250 Acquired 8000.334 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-10-01 Restricted Shares $ M 250 Disposed Common Stock (250) Direct

Footnotes

F1: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date.

F2: Multiple restricted share grants are included in this total.